Biogen (BIIB) Change in Acquisitions & Divestments (2009 - 2026)

Biogen has reported Change in Acquisitions & Divestments for 18 years, with the latest figure at $1.5 billion in Q2 2026.

• On a quarterly basis, Change in Acquisitions & Divestments changed N/A year-over-year to $1.5 billion in Q2 2026; TTM through Jun 2026 was $2.2 billion, a 3862.43% increase from a year earlier, with the FY2025 full-year figure at $23.0 million, changed N/A from the prior year.
• Change in Acquisitions & Divestments was $1.5 billion for Q2 2026 at Biogen, up from $625.2 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $5.7 billion in Q3 2023, with the low at -$96.7 million in Q4 2024.
• Average Change in Acquisitions & Divestments over 5 years is $881.0 million, with a median of $543.6 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2024: Change in Acquisitions & Divestments surged 246.8% in 2023, then sank 99.85% in 2024.
• Over 5 years, Change in Acquisitions & Divestments stood at $566.3 million in 2022, then surged by 906.29% to $5.7 billion in 2023, then plunged by 101.7% to -$96.7 million in 2024, then surged by 65.25% to -$33.6 million in 2025, then soared by 4609.52% to $1.5 billion in 2026.
• The last three Change in Acquisitions & Divestments figures came in at $1.5 billion (Q2 2026), $625.2 million (Q1 2026), and -$33.6 million (Q4 2025), per Business Quant data.